Prot #A4091058: A Phase 3 Randomized, Double-Blind, Active-Controlled, Multicenter Study of the Long-Term Safety and Efficacy of Subcutaneous Administration of Tanezumab in Subjects with Osteoarthritis of the Hip or Knee

Project: Research project

Project Details

StatusActive
Effective start/end date8/25/158/31/21

Funding

  • INC Research, LLC (Prot #A4091058)
  • Pfizer Inc. (Prot #A4091058)